Basilea Pharmaceutica AG/€BSLN

05:30
09:10
12:45
16:25
20:00
1D1W1MYTD1Y5YMAX

About Basilea Pharmaceutica AG

Basilea Pharmaceutica AG is a biopharmaceutical company headquartered in Basel, Switzerland. The company focuses on the research, development, and commercialization of innovative medicines, primarily in the areas of infectious diseases and oncology. Some of its key products include antifungal and antibiotic treatments like Cresemba and Zevtera, which address significant medical needs in their respective markets. Basilea was founded as a spin-off from Roche in 2000, reflecting its strong roots in pharmaceutical research. The company's strategic positioning capitalizes on its expertise in addressing drug-resistant bacterial infections and rare fungal infections, providing solutions where few alternatives exist. Basilea operates on a global scale, collaborating with international partners to expand its research and market reach.

Ticker

€BSLN
Sector

Primary listing

XSWX

Employees

164

Headquarters

Allschwil, Switzerland

BSLN Metrics

BasicAdvanced
€622M
8.62
€5.90
0.71
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy €BSLN

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events
FAQs